Frontlight ResearchEarly access
Trial site
Javorszky Oedoen Korhaz
- 5running trials
- 5closed trials
The trials here
What the 10 trials at this site are about, from their registry records.
- Conditions
- Ulcerative colitis8 trials
- Crohn's disease2 trials
- Phase
- Phase 26 trials
- Phase 34 trials
- Status
- Completed5 trials
- Active, not recruiting4 trials
- Recruiting1 trial
- Lead sponsor
- Cinclus Pharma Holding AB2 trials
- Alvotech Swiss AG1 trial
- Eli Lilly & Co.1 trial
- Hoffmann-La Roche1 trial
- Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)1 trial
- and 4 more
Running trials
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Ulcerative colitis1 recruiting
Closed trials
Withdrawn
Completed
Completed
Completed
A Study to Evaluate MORF-057 in Adults With Moderately to Severely Active UC
Completed
A Study to Test the Effect of TEV-48574 in Moderate to Severe Ulcerative Colitis or Crohn's Disease
Site data: EU CTIS (euclinicaltrials.eu)Updated 17 Nov 2026